Editorial
Published on 19 Apr 2023
Editorial: Emerging talents in pharmacology of anti-cancer drugs 2022
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1191321
- 2,126 views
- 1 citation
Type at least 3 characters
1,812 articles
Original Research
Published on 19 Apr 2023
Assessing the role of lipid-lowering therapy on multi-cancer prevention: A mendelian randomization study
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1109580
- 7,275 views
- 4 citations
Original Research
Published on 19 Apr 2023
Anti-cancer activity of Chaga mushroom (Inonotus obliquus) against dog bladder cancer organoids
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1159516
- 35,306 views
- 21 citations
Review
Published on 19 Apr 2023
A perspective of immunotherapy for acute myeloid leukemia: Current advances and challenges
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1151032
- 10,610 views
- 20 citations
Original Research
Published on 17 Apr 2023
Synergistic effect of CD47 blockade in combination with cordycepin treatment against cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1144330
- 4,134 views
- 10 citations
Original Research
Published on 17 Apr 2023
The value of cuproptosis-related differential genes in guiding prognosis and immune status in patients with skin cutaneous melanoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1129544
- 3,413 views
- 4 citations
Original Research
Published on 17 Apr 2023
Establishment of a 7-gene prognostic signature based on oxidative stress genes for predicting chemotherapy resistance in pancreatic cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1091378
- 2,759 views
- 3 citations
Review
Published on 17 Apr 2023
An updated pharmacological insight into calotropin as a potential therapeutic agent in cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1160616
- 6,856 views
- 11 citations
Original Research
Published on 17 Apr 2023
Synergistic antitumor activity of regorafenib and rosuvastatin in colorectal cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1136114
- 4,726 views
- 11 citations
Original Research
Published on 13 Apr 2023
Chlorophenyl thiophene silicon phthalocyanine: Synthesis, two-photon bioimaging-guided lysosome target, and in vitro photodynamic efficacy
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1168393
- 2,586 views
- 4 citations
Editorial
Published on 13 Apr 2023
Editorial: Anti-cancer bioactive molecules from microbial sources
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1190354
- 3,515 views
- 1 citation
Original Research
Published on 13 Apr 2023
Comparison of pneumonitis risk between immunotherapy alone and in combination with chemotherapy: an observational, retrospective pharmacovigilance study
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1142016
- 5,315 views
- 4 citations
Original Research
Published on 13 Apr 2023
Surface engineered mesoporous silica carriers for the controlled delivery of anticancer drug 5-fluorouracil: Computational approach for the drug-carrier interactions using density functional theory
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1146562
- 3,572 views
- 12 citations
Review
Published on 13 Apr 2023
Role of ferroptosis and its non-coding RNA regulation in hepatocellular carcinoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1177405
- 3,739 views
- 8 citations
Correction
Published on 12 Apr 2023
Corrigendum: Adenosine kinase on deoxyribonucleic acid methylation: Adenosine receptor-independent pathway in cancer therapy
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1200491
- 1,136 views
- 1 citation
Original Research
Published on 12 Apr 2023
I13 overrides resistance mediated by the T315I mutation in chronic myeloid leukemia by direct BCR-ABL inhibition
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1183052
- 2,933 views
- 7 citations